Skip to main navigation Skip to search Skip to main content

CIP2A Inhibits PP2A in Human Malignancies

  • Melissa R. Junttila
  • , Pietri Puustinen
  • , Minna Niemelä
  • , Raija Ahola
  • , Hugh Arnold
  • , Trine Böttzauw
  • , Risto Ala-aho
  • , Christina Nielsen
  • , Johanna Ivaska
  • , Yoichi Taya
  • , Shi-Long Lu
  • , Shujun Lin
  • , Edward K.L. Chan
  • , Xiao-Jing Wang
  • , Reidar Grènman
  • , Jürgen Kast
  • , Tuula Kallunki
  • , Rosalie Sears
  • , Veli-Matti Kähäri
  • , Jukka Westermarck*
  • *Corresponding author for this work
  • Oregon Health and Science University
  • Danish Cancer Society
  • National Cancer Center Research Institute
  • Shenyang University
  • University of British Columbia
  • University of Florida
  • Turku University Hospital
  • Tampere University
  • Tampere University Hospital (TAYS)
  • University of Turku
  • Turku Centre for Biotechnology
  • Åbo Akademi University

Research output: Contribution to journal › Article › Scientific › peer-review

Fingerprint

Dive into the research topics of 'CIP2A Inhibits PP2A in Human Malignancies'. Together they form a unique fingerprint.
Sort by

INIS

Keyphrases

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science